Table 1 Demographic and clinical characteristics of the study population *^{, †}

Age, yrs ^{‡, §}

58.1 ± 14.6

63.7 ± 11.4 ^||

61.4 ± 12.5

68.1 ± 10.2 ^||

BMI, kg/m²

24.3 ± 4.32

24.7 ± 4.01

24.2 ± 4.33

24.6 ± 3.41

Smokers ^{‡, §}

186(33.1%)

253(36.5%) ^||

7(1.6%)

10(2.8%)

Hypertension ^{‡, §}

315(56.0%)

421(60.8%)

269(60.7%)

255(70.8%) ^||

Positive family history

44(7.8%)

31(4.5%)

30(6.8%)

30(8.3%)

Total cholesterol, mmol/L ^{‡, §}

4.63 ± 1.03

4.57 ± 1.03

4.91 ± 1.06

5.08 ± 1.09 ^||

Triglycerides, mmol/L

1.82 ± 1.24

1.93 ± 1.27 ^||

1.74 ± 1.13

1.95 ± 1.19 ^||

LDL cholesterol, mmol/L ^§

2.95 ± 0.90

2.92 ± 0.94

3.04 ± 0.94

3.16 ± 0.97

HDL cholesterol, mmol/L ^{‡, §}

1.06 ± 0.29

1.03 ± 0.34 ^||

1.22 ± 0.30

1.18 ± 0.29 ^||

ApoA-I, mg/L ^‡

1.18 ± 0.44

1.11 ± 0.32 ^||

1.31 ± 0.46

1.25 ± 0.26 ^||

ApoB, mg/L

0.77(0.64-0.88)

0.76(0.61-0.89)

0.78(0.64-0.90)

0.80(0.65-0.97)

LpA, mg/L

0.32(0.25-0.44)

0.34(0.24-0.47)

0.33(0.26-0.41)

0.34(0.26-0.45)

LDL cholesterol/ApoB ratio

3.87(3.46-4.23)

3.81(3.42-4.21)

3.88(3.45-4.29)

3.82(3.51-4.21)

Fasting plasma glucose, mmol/L

5.80 ± 2.23

6.19 ± 2.43 ^||

5.98 ± 2.45

6.32 ± 2.81 ^||

Creatinine, μmol/L ^‡

87.5(73.0-104)

89.0(76.0-104) ^||

69.0(56.0-85.0)

71.0(58.0-89.0) ^||

tHcy, μmol/L ^{‡, §}

13.8 ± 5.93

14.5 ± 6.13 ^||

12.3 ± 5.53

12.9 ± 6.08 ^||

tCys, μmol/L

248.4 ± 46.3

255.8 ± 48.3 ^||

254.2 ± 47.6

251.3 ± 45.5